Effects of Phenobarbital and Levetiracetam on PR and QTc Intervals in Patients with Post-Stroke Seizure

[1]  L. Paletta,et al.  Retrospective evaluation of adverse drug reactions induced by antihypertensive treatment , 2013, Journal of pharmacology & pharmacotherapeutics.

[2]  Mathias Baumert,et al.  Decoupling of QT interval variability from heart rate variability with ageing , 2013, Physiological measurement.

[3]  M. Granner,et al.  Sudden unexpected death in epilepsy: Fatal post-ictal respiratory and arousal mechanisms , 2013, Respiratory Physiology & Neurobiology.

[4]  W. K. Kennedy,et al.  Clinically Significant Drug Interactions with Atypical Antipsychotics , 2013, CNS Drugs.

[5]  V. Krishnan,et al.  Interictal 12-lead electrocardiography in patients with epilepsy , 2013, Epilepsy & Behavior.

[6]  G. De Sarro,et al.  Pharmacokinetic drug-drug interaction and their implication in clinical management , 2013, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[7]  Amy L. Seybert,et al.  Drug-drug interactions contributing to QT prolongation in cardiac intensive care units. , 2013, Journal of critical care.

[8]  B. Gidal,et al.  QTc prolongation by antiepileptic drugs and the risk of torsade de pointes in patients with epilepsy , 2013, Epilepsy & Behavior.

[9]  E. Benjamin,et al.  Electrocardiographic PR Interval and Adverse Outcomes in Older Adults: The Health, Aging, and Body Composition Study , 2013, Circulation. Arrhythmia and electrophysiology.

[10]  D. Hesdorffer,et al.  Sudden Unexpected Death in Epilepsy , 2013, CNS Drugs.

[11]  D. Toni,et al.  Levetiracetam versus Carbamazepine in Patients with Late Poststroke Seizures: A Multicenter Prospective Randomized Open-Label Study (EpIC Project) , 2012, Cerebrovascular Diseases.

[12]  E. Russo,et al.  Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis , 2012, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[13]  G. De Sarro,et al.  Antiepileptic drugs for central post-stroke pain management. , 2012, Pharmacological research.

[14]  Josemir W Sander,et al.  Do antiepileptic drugs or generalized tonic–clonic seizure frequency increase SUDEP risk? A combined analysis , 2012, Epilepsia.

[15]  L. Gallelli,et al.  Phenobarbital/Lamotrigine Coadministration–Induced Blood Dyscrasia in a Patient with Epilepsy , 2010, The Annals of pharmacotherapy.

[16]  G. De Sarro,et al.  Use of Antiepileptic Drugs for Hyperkinetic Movement Disorders , 2010, Current neuropharmacology.

[17]  B. Stricker,et al.  Drug- and non-drug-associated QT interval prolongation. , 2010, British journal of clinical pharmacology.

[18]  B. O. Genc,et al.  Evaluation of cardiac repolarization indices in well-controlled partial epilepsy: 12-Lead ECG findings , 2010, Epilepsy Research.

[19]  Josemir W Sander,et al.  Too long or too short? New insights into abnormal cardiac repolarization in people with chronic epilepsy and its potential role in sudden unexpected death , 2010, Epilepsia.

[20]  G. De Sarro,et al.  Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes , 2010, European Journal of Clinical Pharmacology.

[21]  P. Patsalos,et al.  Drug interactions involving the new second- and third-generation antiepileptic drugs , 2010, Expert review of neurotherapeutics.

[22]  J. Tsai,et al.  Experimental and simulation studies on the mechanisms of levetiracetam-mediated inhibition of delayed-rectifier potassium current (KV3.1): contribution to the firing of action potentials. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[23]  A. Weaver,et al.  Prolonged QTc as a predictor of mortality in acute ischemic stroke. , 2009, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[24]  M. Stewart,et al.  Cardiac Repolarization Indices in Epilepsy Patients , 2009, Cardiology.

[25]  W. Bridson,et al.  Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study. , 2008, Clinical therapeutics.

[26]  H. Tan,et al.  Short QTc in epilepsy patients without cardiac symptoms. , 2007, The Medical journal of Malaysia.

[27]  Mark Josephson,et al.  Implantable Defibrillators and Sudden Cardiac Death , 2004, Circulation.

[28]  G. De Sarro,et al.  Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancer. , 2004, Pharmacological research.

[29]  Claudia Stöllberger,et al.  Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP) , 2004, Epilepsy Research.

[30]  T. Tomson,et al.  Phenytoin and phenobarbital inhibit human HERG potassium channels , 2003, Epilepsy Research.

[31]  G. De Sarro,et al.  Retrospective analysis of adverse drug reactions to bronchodilators observed in two pulmonary divisions of Catanzaro, Italy. , 2003, Pharmacological research.

[32]  G. De Sarro,et al.  Adverse drug reactions to antibiotics observed in two pulmonology divisions of catanzaro, Italy: a six-year retrospective study. , 2002, Pharmacological research.

[33]  Gregory L. Holmes,et al.  The Landau-Kleffner Syndrome , 2001, Epilepsy currents.

[34]  Michael R. Sperling,et al.  Sudden Unexplained Death in Epilepsy , 2001, Epilepsy currents.

[35]  T. Tomson,et al.  Antiepileptic Drug Therapy and Its Management in Sudden Unexpected Death in Epilepsy: A Case–Control Study , 2001, Epilepsia.

[36]  David B. Matchar,et al.  Improving the Reliability of Stroke Subgroup Classification Using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Criteria , 2001, Stroke.

[37]  R. Virmani,et al.  Sudden cardiac death. , 1987, Human pathology.

[38]  B. Bromm,et al.  Phenobarbital induces slow recovery from sodium inactivation at the nodal membrane. , 1980, Biochimica et biophysica acta.

[39]  Kam-Wing Ng,et al.  Improving Reliability for , 2010 .

[40]  M. Ferraro,et al.  Retrospective Evaluation of Adverse Drug Reactions Induced by Nonsteroidal Anti-Inflammatory Drugs , 2007, Clinical drug investigation.

[41]  E. Russo,et al.  Melaena following Use of the Cholinesterase Inhibitor Rivastigmine , 2005, Clinical drug investigation.

[42]  G. De Sarro,et al.  Bilateral Skin Ulceration after Injection of Pegylated Interferon-α-2b in a Patient with Chronic Hepatitis C , 2003, Clinical drug investigation.